Nu-Med Plus completes acquisition of YourSpace America, new CEO and majority control shift

Nu-Med Plus, Inc.

Nu-Med Plus acquires YourSpace America via share exchange; YSA becomes wholly owned subsidiary as of April 28, 2024.
Consideration: 4.5M shares of Series A Preferred (convertible to 90M common shares, 20:1 voting) and 1M Series X Preferred (100:1 voting).
Series X Preferred issued to William R. Colvin, granting him majority voting control of the combined company.
William R. Colvin appointed President, CEO, and Director; former CEO William Hayde becomes Executive Chairman.
An audit of YSA for the prior two fiscal years is pending; amended 8-K to be filed upon completion.

item 2.01 item 3.03 item 3.02 item 1.01 item 5.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

William Hayde

Executive Chairman of the Board

NUMD · Nu-Med Plus, Inc.

Successor: William R. "Russ" Colvin
Filed: May 2, 2024, 7:59 PM ET

Following the appointment of Mr. Colvin as President and Chief Executive Officer, the Company’s former President and CEO William Hayde was appointed to serve as the Company’s Executive Chairman of the Board.

Appointed

William R. "Russ" Colvin

President, Chief Executive Officer, and Director

NUMD · Nu-Med Plus, Inc.

Filed: May 2, 2024, 7:59 PM ET

the Board of Directors of the Company appointed William R. “Russ” Colvin as the Company’s President, Chief Executive Officer, and Director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William Hayde was appointed as Executive Chairman of the Board at Nu-Med Plus, Inc..

Action: appointed
Role: Executive Chairman of the Board

Exact text from the filing

Following the appointment of Mr. Colvin as President and Chief Executive Officer, the Company’s former President and CEO William Hayde was appointed to serve as the Company’s Executive Chairman of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

William R. "Russ" Colvin was appointed as President, Chief Executive Officer, and Director at Nu-Med Plus, Inc..

Action: appointed
Role: President, Chief Executive Officer, and Director

Exact text from the filing

the Board of Directors of the Company appointed William R. “Russ” Colvin as the Company’s President, Chief Executive Officer, and Director of the Company.

View on SEC.gov

Nu-Med Plus, Inc. filing history →

Source: SEC EDGAR

accession 0001548123-24-000067

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.